$1.75
0.2012.90%
At close: -
$1.54
-0.21-12.00%
After Hours: Apr 11, 9:10 AM EDT
Comments
Loading...
CalciMedica Analyst Ratings and Price Targets | NASDAQ:CALC | Benzinga
CalciMedica Inc has a consensus price target of $18 based on the ratings of 6 analysts. The high is $22 issued by JonesTrading on February 16, 2024. The low is $13 issued by LUCID CAPITAL MARKETS on December 17, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co., HC Wainwright & Co., and LUCID CAPITAL MARKETS on April 1, 2025, March 4, 2025, and December 17, 2024, respectively. With an average price target of $15 between HC Wainwright & Co., HC Wainwright & Co., and LUCID CAPITAL MARKETS, there's an implied 874.03% upside for CalciMedica Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
LUCID CAPITAL MARKETS
Oppenheimer
HC Wainwright & Co.
JonesTrading
1calculated from analyst ratings
Analyst Ratings for CalciMedica
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/01/2025 | Buy Now | 938.96% | HC Wainwright & Co. | Joseph Pantginis46% | $16 → $16 | Reiterates | Buy → Buy | Get Alert |
| 03/04/2025 | Buy Now | 938.96% | HC Wainwright & Co. | Joseph Pantginis46% | $16 → $16 | Reiterates | Buy → Buy | Get Alert |
| 12/17/2024 | Buy Now | 744.16% | LUCID CAPITAL MARKETS | Dev Prasad 8% | → $13 | Initiates | → Buy | Get Alert |
| 11/14/2024 | Buy Now | 938.96% | HC Wainwright & Co. | Joseph Pantginis46% | $16 → $16 | Reiterates | Buy → Buy | Get Alert |
| 11/04/2024 | Buy Now | 938.96% | HC Wainwright & Co. | Joseph Pantginis46% | $20 → $16 | Maintains | Buy | Get Alert |
| 08/13/2024 | Buy Now | 1198.7% | HC Wainwright & Co. | Joseph Pantginis46% | $20 → $20 | Reiterates | Buy → Buy | Get Alert |
| 07/10/2024 | Buy Now | 1198.7% | Oppenheimer | Leland Gershell70% | $14 → $20 | Maintains | Outperform | Get Alert |
| 07/09/2024 | Buy Now | 1198.7% | HC Wainwright & Co. | Joseph Pantginis46% | $20 → $20 | Reiterates | Buy → Buy | Get Alert |
| 06/27/2024 | Buy Now | 1198.7% | HC Wainwright & Co. | Joseph Pantginis46% | $20 → $20 | Reiterates | Buy → Buy | Get Alert |
| 05/14/2024 | Buy Now | 1198.7% | HC Wainwright & Co. | Joseph Pantginis46% | $20 → $20 | Reiterates | Buy → Buy | Get Alert |
| 04/01/2024 | Buy Now | 1198.7% | HC Wainwright & Co. | Swayampakula Ramakanth50% | $20 → $20 | Reiterates | Buy → Buy | Get Alert |
| 04/01/2024 | Buy Now | 809.09% | Oppenheimer | Leland Gershell70% | $14 → $14 | Maintains | Outperform | Get Alert |
| 03/13/2024 | Buy Now | 1198.7% | HC Wainwright & Co. | Joseph Pantginis46% | $20 → $20 | Reiterates | Buy → Buy | Get Alert |
| 02/16/2024 | Buy Now | 1328.57% | JonesTrading | Catherine Novack34% | → $22 | Initiates | → Buy | Get Alert |
| 02/13/2024 | Buy Now | 1198.7% | HC Wainwright & Co. | Joseph Pantginis46% | $20 → $20 | Reiterates | Buy → Buy | Get Alert |
| 01/29/2024 | Buy Now | 1198.7% | HC Wainwright & Co. | Joseph Pantginis46% | → $20 | Initiates | → Buy | Get Alert |
| 11/13/2023 | Buy Now | 809.09% | Oppenheimer | Leland Gershell70% | → $14 | Reiterates | Outperform → Outperform | Get Alert |
| 07/07/2023 | Buy Now | 1003.9% | EF Hutton | Tony Butler42% | → $17 | Reiterates | Buy → Buy | Get Alert |
| 06/20/2023 | Buy Now | 1003.9% | EF Hutton | Tony Butler42% | → $17 | Initiates | → Buy | Get Alert |
| 05/16/2023 | Buy Now | 809.09% | Oppenheimer | Leland Gershell70% | → $14 | Reiterates | → Outperform | Get Alert |
| 03/24/2023 | Buy Now | 809.09% | Oppenheimer | Leland Gershell70% | → $14 | Initiates | → Outperform | Get Alert |
FAQ
What is the target price for CalciMedica (CALC) stock?
The latest price target for CalciMedica (NASDAQ:CALC) was reported by HC Wainwright & Co. on April 1, 2025. The analyst firm set a price target for $16.00 expecting CALC to rise to within 12 months (a possible 938.96% upside). 10 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for CalciMedica (CALC)?
The latest analyst rating for CalciMedica (NASDAQ:CALC) was provided by HC Wainwright & Co., and CalciMedica reiterated their buy rating.
When was the last upgrade for CalciMedica (CALC)?
There is no last upgrade for CalciMedica
When was the last downgrade for CalciMedica (CALC)?
There is no last downgrade for CalciMedica.
When is the next analyst rating going to be posted or updated for CalciMedica (CALC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CalciMedica, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CalciMedica was filed on April 1, 2025 so you should expect the next rating to be made available sometime around April 1, 2026.
Is the Analyst Rating CalciMedica (CALC) correct?
While ratings are subjective and will change, the latest CalciMedica (CALC) rating was a reiterated with a price target of $16.00 to $16.00. The current price CalciMedica (CALC) is trading at is $1.54, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
